Leuprolide acetate depot 3.75 mg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Leuprolide acetate depot 3.75 mg, covering 2007-11-14 to 2007-11-14. Get the full timeline:
Most recent: Clinical Trial Update: Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer [Phase 3]